Loading stock data…
EDAP TMS S.A. (FOCL)
$6.03-0.06 (-0.99%)
Market ClosedLast close Jul 24
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
EDAP TMS S.A. in the Healthcare sector is trading at $6.03 with a market capitalization of $169M. Wall Street consensus targets $8.50 (5 analysts), implying a +41.0% move over the next 12 months. The stock is currently near its 52-week high of $6.18, remaining 62.5% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +41.0% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $17.81M↓ | $51.61M↑ | $16.28M↓ | $18.81M↑ | $14.27M |
| Gross Profit | $8.15M↓ | $21.86M↑ | $7.01M↓ | $8.00M↑ | $5.99M |
| Operating Income | -$7.37M↑ | -$17.98M↓ | -$5.78M↑ | -$6.76M↓ | -$6.31M |
| Net Income | -$9.08M↑ | -$22.41M↓ | -$5.88M↑ | -$6.57M↑ | -$7.44M |
Peer Comparison
JNJUNHPFE
Fundamentals
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company o...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$169.42M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
0.00
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-435.03%
Volume
Today's trading volume
47,827
Recent News
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
European equities traded in the US as American depositary receipts were tracking lower late Thursday
European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
European equities traded in the US as American depositary receipts started the week lower late Monda
EDAP TMS (EDAP) Stock Fair Value Rises As HIFU Narrative Gains Ground
The latest analyst update on EDAP TMS centers on a revised fair value price target, moving from US$6.83 to US$8.50. That shift is tied to how analysts view high intensity focused ultrasound in prostate cancer, alongside potential upside from areas like benign prostatic hyperplasia and endometriosis that are often treated as optionality rather than fully reflected in core models. Read on to see what is driving this evolving narrative and how you can track it over time. Analyst Price Targets...
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
European equities traded in the US as American depositary receipts were sharply higher late Thursday
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
European equities traded in the US as American depositary receipts were trending higher late Monday